Evidence map›Paper›PMID 19695255›Full record

ArticleInternational journal for parasitology2010

Vaccination-induced IgG response to Galalpha1-3GalNAc glycan epitopes in lambs protected against Haemonchus contortus challenge infection.

Caroline M W van Stijn, Marloes van den Broek, Lonneke Vervelde, Richard A Alvarez, Richard D Cummings, Boris Tefsen, Irma van Die

Open access · bronzeAbstract read
In one paragraph

Article in International journal for parasitology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
3.1field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 41 citations in OpenAlex.

  1. Article
  2. The Role ofPathogens (Basel, Switzerland) · 2025
    Article
  3. Serum antibody screening using glycan arrays.Chemical Society reviews · 2024
    Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. N-glycome and N-glycoproteome of a hematophagous parasitic nematodeComputational and structural biotechnology journal · 2021
    Article
  9. Review
  10. Infection withVaccines · 2020
    Article
  11. Review
  12. Review
  13. Article
  14. The Journal of biological chemistry · 2017
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Glycoconjugates in host-helminth interactions.Frontiers in immunology · 2013
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Caroline M W van StijnDepartment of Molecular Cell Biology & Immunology, VU University Medical Center, van der Boechorststraat 7, 1081 BT Amsterdam, The Netherlands.
Marloes van den Broek
Lonneke Vervelde
Richard A Alvarez
Richard D Cummings
Boris Tefsen
Irma van Die
Amsterdam UMC Location VUmc · NLUniversity of Oklahoma Health Sciences Center · USUtrecht University · NL

Funding

Structural Basis of Immune Recognition of Glycosylated AntigensU54GM062116 · NIGMS · SCRIPPS RESEARCH INSTITUTE, THE · PI ALVAREZ, RICHARD · 2001 to 2010
$80.3M
'Immunity of Schistosome Glycoconjugates'R01AI047214 · NIAID · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI CUMMINGS, RICHARD D · 2001 to 2003
$637k
NIAID NIH HHS R01 AI047214NIGMS NIH HHS GM62116
6 · The paper itself

Abstract

Lambs vaccinated with Haemonchus contortus excretory/secretory (ES) glycoproteins in combination with the adjuvant Alhydrogel are protected against H. contortus challenge infection. Using glycan micro-array analysis we showed that serum from such vaccinated lambs contains IgG antibodies that recognise the glycan antigen Galalpha1-3GalNAc-R and GalNAcbeta1-4(Fucalpha1-3)GlcNAc-R. Our studies revealed that H. contortus glycoproteins contain Galalpha1-3Gal-R as well as significant levels of Galalpha1-3GalNAc-R, which has not been previously reported. Extracts from H. contortus adult worms contain a galactosyltransferase acting on glycan substrates with a terminal GalNAc, indicating that the worms possess the enzymatic potential to synthesise terminal Gal-GalNAc moieties. These data illustrate that glycan micro-arrays constitute a promising technology for fast and specific analysis of serum anti-glycan antibodies in vaccination studies. In addition, this approach facilitates the discovery of novel, antigenic parasite glycan antigens that may have potential for developing glycoconjugate vaccines or utilization in diagnostics.

Indexed as

AnimalsAntibodies, HelminthDisaccharidesGlycoproteinsHaemonchiasisHaemonchusHelminth ProteinsImmunoglobulin GSheepSheep DiseasesVaccinationVaccinesAntibodies, HelminthDisaccharidesgalactosyl-(1-3)galactoseGlycoproteinsHelminth ProteinsImmunoglobulin GVaccines

Identifiers

PMID19695255
PMCPMC2813329
OpenAlexW2132015526

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.